AI assistant
Sending…
RESMED INC — Director's Dealing 2019
Nov 22, 2019
30071_dirs_2019-11-22_cc536ad3-a0c7-432f-b98e-31394092434a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2019-11-21
Reporting Person: Sodhi Rajwant (President, SaaS Business)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-11-21 | ResMed Common Stock | A | 23594 | $146.34 | Acquired | 54381 | Direct |
| 2019-11-21 | ResMed Common Stock | F | 13161 | $146.34 | Disposed | 41220 | Direct |
Footnotes
F1: Represents performance-based restricted stock units granted on November 16, 2016. The shares were earned on November 21, 2019, when the compensation committee certified that the performance metrics were met.
F2: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016.
More from RESMED INC
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Regulatory Filings
2026
Jan 29
Director's Dealing
2026
Jan 9